Asset Details
Do you wish to reserve the book?
Effect of a single vectored thermal pulsation treatment of Meibomian gland dysfunction patients under controlled environmental conditions
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Effect of a single vectored thermal pulsation treatment of Meibomian gland dysfunction patients under controlled environmental conditions
Do you wish to request the book?
Effect of a single vectored thermal pulsation treatment of Meibomian gland dysfunction patients under controlled environmental conditions
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Effect of a single vectored thermal pulsation treatment of Meibomian gland dysfunction patients under controlled environmental conditions
2022
Overview
To assess the prophylactic effect of LipiFlow treatment in Meibomian gland dysfunction (MGD) patients exposed to an adverse environmental humidity. MGD patients were exposed to normal (23 °C; 50% relative humidity; 30 min) and adverse (23 °C; 10% relative humidity; 2 h) controlled environments consecutively during baseline and follow-up visits (3, 6, and 12 months) after a single LipiFlow treatment. Ocular Surface Disease Index (OSDI), lipid layer thickness (LLT), fluorescein tear break-up time (TBUT), corneal and conjunctival staining, change in dry eye symptoms questionnaire (CDES-Q), and Meibomian gland yielding liquid secretion (MGYLS), were assessed. Linear mixed-effects and cumulative logit mixed models were fitted to assess the effect of the LipiFlow treatment over time and within the controlled environments. Seventeen females and 4 males (59.6 ± 9.4 years) completed the study. LLT and TBUT did not vary significantly (
p
> 0.05) after LipiFlow treatment. OSDI, corneal and conjunctival staining, and MGYLS scores were improved (
p
≤ 0.01) 12 months after treatment. After the adverse exposure, corneal staining increased at all visits (
p
= 0.01), and there was no significant improvement in CDES-Q scores after LipiFlow treatment (
p
≥ 0.07). One LipiFlow treatment improved objective and subjective outcomes in MGD disease for at least one year. Further studies are needed to support that LipiFlow might also help as an adjuvant to avoid acute flares against an adverse environmental humidity.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
